• 2018-07
  • 2020-07
  • 2020-08
  • br Gilam A Conde J Weissglas


    48. Gilam A, Conde J, Weissglas-Volkov D, Oliva N, Friedman E, Artzi N, Shomron N: Local MicroRNA delivery targets palladin and prevents metastatic breast cancer. Nat Commun 2016, 7:12868
    52. Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM, Isaacs WB: Alpha-Methylacyl-Coa Racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 2003, 63:7365e7376
    53. Rubin MA, Bismar TA, Andren O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE: Decreased alpha-methylacyl CoA racemase CH 223191 in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev 2005, 14:1424e1432
    Kurth T, Mucci LA, Rubin MA: a-Methylacyl-Coa racemase expression and lethal prostate cancer in the Physicians’ Health Study and Health Professionals follow-up study. Prostate 2012, 72: 301e306
    55. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko CH 223191 JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR: A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol 2014, 66:550e560
    56. Mo W, Zhang J, Li X, Meng D, Gao Y, Yang S, Wan X, Zhou C, Guo F, Huang Y, Amente S, Avvedimento EV, Xie Y, Li Y: Iden-tification of novel AR-targeted microRNAs mediating androgen sig-nalling through critical pathways to regulate cell viability in prostate cancer. PLoS One 2013, 8:e56592
    58. Howley BV, Link LA, Grelet S, El-Sabban M, Howe PH: A CREB3-regulated ER-Golgi trafficking signature promotes metastatic pro-gression in breast cancer. Oncogene 2017, 10:1308e1325 59. Gurel B, Lucia MS, Thompson IM Jr, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA: Chronic inflamma-tion in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2014, 23:847e856
    922 - The American Journal of Pathology
    High miR-182 in Low-Risk Prostate Cancer
    60. Lin HM, Mahon KL, Weir JM, Mundra PA, Spielman C, Briscoe K, Gurney H, Mallesara G, Marx G, Stockler MR, Consortium PR, Parton RG, Hoy AJ, Daly RJ, Meikle PJ, Horvath LG: A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer. Int J Cancer 2017, 141:2112e2120
    61. Sato A, Asano T, Ito K, Asano T: Vorinostat and bortezomib syn-ergistically cause ubiquitinated protein accumulation in prostate cancer cells. J Urol 2012, 188:2410e2418 
    63. DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, Jemal A: Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 2016, 66:290e308
    The American Journal of Pathology - 923 Accepted Manuscript
    Association of KIR genes and their HLA ligands diversity with colorectal cancers in Lur population of Iran
    Bahareh Shayanrad, Koroush Ghanadi, Ali-mohammad Varzi, Mehdi Birjandi, Seyyed Amir Yasin Ahmadi, Farhad Shahsavar
    Please cite this article as: B. Shayanrad, K. Ghanadi, A.-m. Varzi, et al., Association of KIR genes and their HLA ligands diversity with colorectal cancers in Lur population of Iran, Meta Gene,
    This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
    Association of KIR genes and their HLA ligands Diversity with Colorectal Cancers in
    Lur Population of Iran
    Bahareh Shayanrad1, 2, Koroush Ghanadi3, Ali-mohammad Varzi2, Mehdi Birjandi4, Seyyed Amir Yasin Ahmadi5, 6, Farhad Shahsavar2*
    1 Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
    2 Department of Immunology, Lorestan University of Medical Sciences, Khorramabad, Iran
    3 Division of Gastroenterology, Department of Internal Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
    4 Department of Epidemiology and Biostatistics, Lorestan University of Medical Sciences, Khorramabad, Iran